Pharma News, 2018

The Biocon plant in Bangalore, India, where it manufacturers biosimilars has been issued an FDA EIR after having been cited with a Form 483 last year.

ORLANDO, Fla.

Achaogen got some anticipated good news Tuesday with an FDA nod for its high-powered antibiotic Zemdri, but it wasn't an unqualified win.

FRANKFURT (Reuters) - German chemicals group BASF has shut down production of ibuprofen at its plant in Bishop, Texas because of a technical problem, a spokesman for BASF said on Wednesday.

Spectrum Pharmaceuticals Inc.

LONDON (Reuters) - GlaxoSmithKline is facing “unprecedented” demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger money-spinner than the company and analy...

The U.

CAMBRIDGE, Mass.

Lupin pharmaceuticals has entered into an agreement with Nichi-Iko for the distribution, promotion, and sale of its proposed biosimilar etanercept, YLB113, in Japan.

Washington.

LONDON (Reuters) - A venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $350 million, far exceeding the initial target of $200 million set on its launc...

(Reuters) - Pfizer Inc said on Monday a combination of its breast cancer drug, Ibrance, and another drug was not statistically significant in extending overall survival in certain patients, th...